Phibro Animal Health (PAHC) Net Margin (2012 - 2026)

Phibro Animal Health's Net Margin history runs 15 years deep, the most recent figure standing at 6.26% for Q1 2026.

• On a quarterly basis, Net Margin rose 26.0% year-over-year to 6.26% in Q1 2026; TTM through Mar 2026 was 6.35%, a 752.0% increase from a year earlier, with the FY2025 full-year figure at 3.72%, up 798.0% from the prior year.
• Net Margin declined to 6.26% in Q1 2026 per PAHC's latest filing, from 7.34% in the prior quarter.
• Across five years, Net Margin topped out at 7.38% in Q1 2022 and bottomed at 16.47% in Q2 2024.
• The 5-year median for Net Margin is 3.19% (2024), against an average of 2.5%.
• Across the five-year window, Net Margin plunged 2097 bps in 2024 and soared 2101 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 2.95% in 2022, then tumbled by 83 bps to 0.51% in 2023, then surged by 102 bps to 1.03% in 2024, then soared by 613 bps to 7.34% in 2025, then retreated by 15 bps to 6.26% in 2026.
• Per Business Quant, the three latest PAHC Net Margin figures stand at 6.26% (Q1 2026), 7.34% (Q4 2025), and 7.29% (Q3 2025).